Health & bio

Stanford study: 10% of patients show GLP-1 resistance

One in ten patients on GLP-1 diabetes medications may experience diminished response. Next-generation targets needed.

Primary sources · 1
Stanford Med
← View the full 2026-04-21 (Tue) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →